325 related articles for article (PubMed ID: 17387156)
1. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
[TBL] [Abstract][Full Text] [Related]
2. Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?
Hareza DA; Cosgrove SE; Simner PJ; Harris AD; Bergman Y; Conzemius R; Jacobs E; Beisken S; Tamma PD
Clin Infect Dis; 2024 May; 78(5):1103-1110. PubMed ID: 37972276
[TBL] [Abstract][Full Text] [Related]
3. Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.
Palacios-Baena ZR; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale P; Oliver A; Pintado V; Gasch O; Martínez-Martínez L; Pitout J; Akova M; Peña C; Molina Gil-Bermejo J; Hernández A; Venditti M; Prim N; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Giamarellou H; Almela M; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Paño-Pardo JR; Torre-Cisneros J; Souli M; Bonomo RA; Carmeli Y; Paterson DL; Pascual Á; Rodríguez-Baño J;
Clin Infect Dis; 2017 Oct; 65(10):1615-1623. PubMed ID: 29020250
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
Falcone M; Russo A; Iraci F; Carfagna P; Goldoni P; Vullo V; Venditti M
Antimicrob Agents Chemother; 2016 Jan; 60(1):252-7. PubMed ID: 26482315
[TBL] [Abstract][Full Text] [Related]
5. Trends in paediatric bloodstream infections at a South African referral hospital.
Dramowski A; Cotton MF; Rabie H; Whitelaw A
BMC Pediatr; 2015 Apr; 15():33. PubMed ID: 25884449
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.
Endimiani A; Luzzaro F; Pini B; Amicosante G; Rossolini GM; Toniolo AQ
BMC Infect Dis; 2006 Mar; 6():52. PubMed ID: 16542460
[TBL] [Abstract][Full Text] [Related]
7. Mortality, hospital length of stay, and recurrent bloodstream infections associated with extended-spectrum beta-lactamase-producing Escherichia coli in a low prevalence region: A 20-year population-based large cohort study.
Ling W; Paterson DL; Harris PNA; Furuya-Kanamori L; Edwards F; Laupland KB
Int J Infect Dis; 2024 Jan; 138():84-90. PubMed ID: 37949363
[TBL] [Abstract][Full Text] [Related]
8. Frequency and mortality rate following antimicrobial-resistant bloodstream infections in tertiary-care hospitals compared with secondary-care hospitals.
Lim C; Hantrakun V; Klaytong P; Rangsiwutisak C; Tangwangvivat R; Phiancharoen C; Doung-Ngern P; Kripattanapong S; Hinjoy S; Yingyong T; Rojanawiwat A; Unahalekhaka A; Kamjumphol W; Khobanan K; Leethongdee P; Lorchirachoonkul N; Khusuwan S; Siriboon S; Chamnan P; Vijitleela A; Fongthong T; Noiprapai K; Boonyarit P; Srisuphan V; Sartorius B; Stelling J; Turner P; Day NPJ; Limmathurotsakul D
PLoS One; 2024; 19(5):e0303132. PubMed ID: 38768224
[TBL] [Abstract][Full Text] [Related]
9. Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study.
Guedes M; Gathara D; López-Hernández I; Pérez-Crespo PMM; Pérez-Rodríguez MT; Sousa A; Plata A; Reguera-Iglesias JM; Boix-Palop L; Dietl B; Blanco JS; Castillo CA; Galán-Sánchez F; Kindelán CN; Jover-Saenz A; Aguirre JG; Alemán AA; Ciordia TM; Del Arco Jiménez A; Fernandez-Suarez J; Lopez-Cortes LE; Rodríguez-Baño J;
Ann Clin Microbiol Antimicrob; 2024 May; 23(1):42. PubMed ID: 38711045
[TBL] [Abstract][Full Text] [Related]
10. Microbiological profile of bloodstream infections and antimicrobial resistance patterns at a tertiary referral hospital in Amazon, Brazil.
Ferreira EDS; Gómez ASP; Almeida TVR; Frank CHM; Melo SA; Marinho EPM; Pinto SD; Feitoza PVS; Monte RL; Bastos MS
Rev Soc Bras Med Trop; 2023; 56():e03822023. PubMed ID: 37792844
[TBL] [Abstract][Full Text] [Related]
11. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.
Bergin SP; Thaden JT; Ericson JE; Cross H; Messina J; Clark RH; Fowler VG; Benjamin DK; Hornik CP; Smith PB;
Pediatr Infect Dis J; 2015 Sep; 34(9):933-6. PubMed ID: 26065862
[TBL] [Abstract][Full Text] [Related]
12. Clinical prediction tool for extended-spectrum beta-lactamase-producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients.
Wang R; Han JH; Lautenbach E; Tamma PD; Thom KA; Alby K; Blumberg EA; Bilker WB; Werzen A; Omorogbe J; Tolomeo P; Anesi JA
Transpl Infect Dis; 2021 Aug; 23(4):e13599. PubMed ID: 33724633
[TBL] [Abstract][Full Text] [Related]
13. Available evidence of antibiotic resistance from extended-spectrum β-lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: a systematic review and meta-analysis.
Hu YJ; Ogyu A; Cowling BJ; Fukuda K; Pang HH
Bull World Health Organ; 2019 Jul; 97(7):486-501B. PubMed ID: 31258218
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic Prescriptions in Critically Ill Patients with Bloodstream Infection Due to ESBL-Producing Enterobacteriaceae: Compliance with the French Guidelines for the Treatment of Infections with Third-Generation Cephalosporin-Resistant Enterobacteriaceae-A Multicentric Retrospective Cohort Study.
Le Berre C; Houard M; Vachée A; Georges H; Wallet F; Patoz P; Herbecq P; Nseir S; Delannoy PY; Meybeck A
Microorganisms; 2023 Oct; 11(11):. PubMed ID: 38004688
[TBL] [Abstract][Full Text] [Related]
15. Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998-2007.
Al-Hasan MN; Lahr BD; Eckel-Passow JE; Baddour LM
Clin Microbiol Infect; 2011 Apr; 17(4):539-45. PubMed ID: 20518795
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics, Prognosis and Treatment of Bloodstream Infections with
Liu Y; Li F; Fang Y; Zhong Q; Xiao Y; Zheng Y; Zhu J; Zhao C; Cao X; Xiong J; Hu L
Infect Drug Resist; 2024; 17():1811-1825. PubMed ID: 38741943
[TBL] [Abstract][Full Text] [Related]
17. Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study.
Roseau-Vincenti A; Forestier E; Lanoix JP; Ricard C; Carret MC; Caraux-Paz P; Paccalin M; Gavazzi G; Roubaud-Baudron C;
Infection; 2024 Feb; 52(1):155-163. PubMed ID: 37608043
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
Lester R; Musicha P; van Ginneken N; Dramowski A; Hamer DH; Garner P; Feasey NA
J Antimicrob Chemother; 2020 Mar; 75(3):492-507. PubMed ID: 31742611
[TBL] [Abstract][Full Text] [Related]
19. The clinical impact of early detection of ESBL-producing Enterobacterales with PCR-based blood culture assays.
Chang KM; Haghamad A; Saunders-Hao P; Shaffer A; Mirsaidi N; Zimilover A; Epstein M; Jain S; Streva V; Juretschko S; Demissie S; Gautam-Goyal P
Am J Infect Control; 2024 Jan; 52(1):73-80. PubMed ID: 37544512
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study.
Savage RD; Fowler RA; Rishu AH; Bagshaw SM; Cook D; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall J; Martin CM; McIntyre L; Muscedere J; Reynolds S; Stelfox HT; Daneman N
PLoS One; 2016; 11(5):e0154944. PubMed ID: 27152615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
